Shell’s first-quarter adjusted earnings fell by less than expected, and the oil major kicked off a share buyback as it hurried to close the valuation gap to its U.S. rivals.

The fitness-equipment maker has warned of cash-flow issues and continued losses amid a decline in paying subscribers and a recall.

Emergent BioSolutions is closing several manufacturing facilities and cutting hundreds of jobs as part of a restructuring as the company narrows its focus on products, including Narcan nasal spray.

Antitrust enforcers are set to allege former Pioneer CEO Scott Sheffield discussed coordinating oil-production levels with other producers and OPEC.

The company’s Medicare business, hit by higher medical costs, pushed down CVS’s first-quarter earnings.

The Brazilian aircraft maker has been sounding out potential partners and financial backers on plans for a new narrow-body aircraft.